Phase III APPOINT-PNH study of investigational oral monotherapy iptacopan met its primary endpoint; second positive…
The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated…
Domain Therapeutics strengthens Scientific Advisory Board with appointment of immuno-oncology experts Global key opinion leaders,…
Addex to receive USD 1 million in additional research funding Collaboration continues to advance through…
Singapore, Dec 8, 2022 – (ACN Newswire) – G.H.Y Culture & Media Holding Co., Limited…
Report from insightsoftware and Hanover Research reveals the gaps that need to be bridged to…
Reinvention ‘reset’ seen as critical to achieving a more resilient, agile, sustainable, innovative and profitable…
HONG KONG, Dec 8, 2022 – (ACN Newswire) – Hypebeast, a leading online destination for…
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Federal Court to weigh controversial bill that PIC argues is an unlawful targeting of scientific…
NGM707 was generally well tolerated to the highest dose evaluated (1800 mg) in the monotherapy…
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec….
RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage…
Delta, British Columbia–(Newsfile Corp. – December 7, 2022) – Fab-Form Industries Ltd. (TSXV: FBF) (“Fab-Form”)…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Dr. Mike Chang to transition to Executive Chairman and Mr. Stephen Chang to become Chief…
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
St. Julians, Malta–(Newsfile Corp. – December 7, 2022) – Esports Entertainment Group, Inc. (NASDAQ: GMBL)…
Toronto, Ontario and New York, New York–(Newsfile Corp. – December 7, 2022) – QuantGate Systems,…
Ottawa, Ontario–(Newsfile Corp. – December 7, 2022) – Enablence Technologies Inc. (TSXV: ENA) (“Enablence” or…